logo BDSP

Base documentaire

  1. Effect of routine use of therapy in slowing the clinical course of human immunodeficiency virus (HIV) infection in a population-based cohort.

    Article - En anglais

    Clinical trials have shown that the prophylactic use of zidovudine and aerosolized pentamidine (or other antibiotics used as prophylaxis against Pneumocystis carinii pneumonia) in acquired immunodeficiency syndrome (AIDS)-free human immunodeficiency virus (HIV)-infected persons delays the development of AIDS, but the effectiveness of such therapy in general use in the population still remains largely undocumented.

    To help answer this question, the authors estimate the effectiveness of this therapy in a population-based cohort of HIV-infected homosexual and bisexual men in San Francisco.

    Mots-clés Pascal : Zidovudine, Antibiotique, Immunodéficit acquis syndrome, Virose, Infection, Antiviral, Pentamidine, Chimiothérapie, Efficacité traitement, Immunopathologie, Hémopathie, Séropositivité, Lymphocyte T, Etats Unis, Amérique du Nord, Amérique, Antigène CD4, Virus immunodéficience humaine, Lentivirinae, Retroviridae, Virus, Evolution, Développement maladie, Modèle statistique

    Mots-clés Pascal anglais : Antibiotic, AIDS, Viral disease, Infection, Antiviral, Chemotherapy, Treatment efficiency, Immunopathology, Hemopathy, Seropositivity, T-Lymphocyte, United States, North America, America, Human immunodeficiency virus, Lentivirinae, Retroviridae, Virus, Evolution, Disease development, Statistical model

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 93-0549338

    Code Inist : 002B02S05. Création : 199406.